Allergy and dermatology US treatment guidelines review for adults with atopic dermatitis
This article highlights the fact that although the updated management guidelines for adults with AD in dermatology and allergy align on certain recommendations, notable differences that could influence clinical decision making remain. Despite both sets of guidelines being evidence-based, variations in recommendations arise when factoring in patient preferences, perspectives, and risk aversion. As newer treatments become available for patients with AD, it will be important to monitor the evolving concordance or discordance of these guidelines given their direct impact on patient care.
Authors
- Richard Bindernagel (ORCID: https://orcid.org/0000-0002-2280-6692)
- Dennis K. Ledford (ORCID: https://orcid.org/0000-0003-2541-7075)
- Constance Bindernagel (ORCID: https://orcid.org/0009-0002-2134-5051)
- Monica Hajirawala (ORCID: https://orcid.org/0000-0003-2138-806X)
- Richard Miller (ORCID: https://orcid.org/0009-0004-4884-3071)
- Baylee Fulford
- Henry Tremain
Institutions
- Johns Hopkins University (US)
- Nova Southeastern University (US)
- Center for Clinical and Cosmetic Research (US)
- James A. Haley Veterans' Hospital (US)
- Johns Hopkins All Children's Hospital (US)
- Florida Center for Gastroenterology (US)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1016/j.jacig.2025.100569
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00